Clincosm LogoSign in Get a demo

MOOD: The Place of Consultations Specializing in the Diagnosis of Mood Disorders in Strasbourg University Hospital

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05145790
Collaborator
(none)
197
Enrollment
1
Location
7
Anticipated Duration (Months)
28.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Mood disorders (depressive disorders and bipolar disorders) are among the ten most worrying diseases of the 21st century according to the WHO.

In order to support psychiatrists in their diagnostic reflection, structures have been created. Since 2009, the Psychiatry Service 2 within the Psychiatry, Mental Health and Addictology Pole of the University Hospitals of Strasbourg has offered specialized consultations in mood disorders.

More than 10 years after the creation of these consultations, it seems interesting to study the profile of the users and to describe the nature of the reports of these in-depth evaluation consultations (diagnosis, therapeutic advice)

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    197 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    State of Play in Strasbourg University Hospital of the Place of Consultations Specializing in the Diagnosis of Mood Disorders
    Actual Study Start Date :
    Aug 15, 2021
    Anticipated Primary Completion Date :
    Mar 1, 2022
    Anticipated Study Completion Date :
    Mar 15, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Descriptive study of the clinical characteristics of patients coming to consultations specializing in mood disorders in Strasbourg University Hospitals [Files analysed retrospectively from January 01, 2018 to December 31, 2019 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion criteria:

    • Major subject

    • Specialized primary consultation highlighting symptoms of mood disorders with Prof. Berstchy in the psychiatry department 2 in the University Hospital of Strasbourg (patients whose consultation request was linked to symptoms or a diagnosis of ADHD will not be included in the study population).

    • Consultation that took place in 2018 and 2019.

    • Patient who did not express his opposition to the reuse of his data for scientific research purposes.

    Exclusion criteria:

    • Patient opposition to the use of their personal data for scientific research purposes.

    • Prior existence of a previous specialist consultation in mood disorders with Prof. Berstchy (the information collected during the first consultation is not accessible)

    • Patient under curatorship, guardianship or legal protection

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Principal Investigator: Gilles BERTSCHY, MD, PhD, Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05145790
    Other Study ID Numbers:
    • 8365
    First Posted:
    Dec 6, 2021
    Last Update Posted:
    Dec 15, 2021
    Last Verified:
    Nov 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Mood Disorders
    Additional relevant MeSH terms:
    Disease
    Mood Disorders

    Study Results

    No Results Posted as of Dec 15, 2021